CARRIE PHILLIPS: Open Payments
NPI 1104075415 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,186 in 116 payments from 19 companies in 2025. Trend: 2023 $2,107 · 2024 $2,130 · 2025 $2,186
Food & beverage: $2,087Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $825 |
| Novartis Pharmaceuticals Corporation | 32 | $559 |
| UCB, Inc. | 8 | $167 |
| Amgen Inc. | 10 | $149 |
| Janssen Biotech, Inc. | 1 | $99 |
| PFIZER INC. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| GENZYME CORPORATION | 2 | $47 |
| Boston Scientific Corporation | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
Products named: COSENTYX, RINVOQ, SKYRIZI, Bimzelx, TREMFYA, OTEZLA, XELJANZ, ORENCIA.
Industry payments across GA — which companies pay providers there.
